DRUGSSON
DRUGSSON is a subsidiary of Double Bond Pharmaceutical AB.
Double Bond Pharmaceutical was founded in 2014 and is a fast-growing pharmaceutical company which develops and commercializes first-in-class products for the treatment of various types of cancer, infections, autoimmune and other life-threatening diseases.
DRUGSSON targets unique and novel products. We aim to be a contender in the Nordics and the non-regulated countries, providing patients with high quality, effective and easy to use products, for all ages.
DRUGSSON distributes products that are already registered in the EU from partners/future partners. DRUGSSON also provides expertise in the distribution and RA field in order to help partners register their products in the EU market.
Although being a young company, DRUGSSON already distributes two medical devices and several Biocidal products in the Nordic regions.
We are constantly searching for opportunities to in-license more products to our pipeline.
Company summary
The company’s primary goal is to provide patients and the market with more efficient and safer products, especially in those areas where these needs have not been met or are unsatisfied.
Markets and services
DRUGSSON distributes products such as Medical devices, Biocides and Pharmaceuticals to the Nordic regions as well as the non-regulated markets. DRUGSSON’s distribution channels comprise of Pharmacies (both online and physical), hospitals, companies/industries, supermarkets and laboratories.
DRUGSSON
DRUGSSON is a subsidiary of Double Bond Pharmaceutical AB.
Double Bond Pharmaceutical was founded in 2014 and is a fast-growing pharmaceutical company which develops and commercializes first-in-class products for the treatment of various types of cancer, infections, autoimmune and other life-threatening diseases.
DRUGSSON targets unique and novel products. We aim to be a contender in the Nordics and the non-regulated countries, providing patients with high quality, effective and easy to use products, for all ages.
DRUGSSON distributes products that are already registered in the EU from partners/future partners. DRUGSSON also provides expertise in the distribution and RA field in order to help partners register their products in the EU market.
Although being a young company, DRUGSSON already distributes two medical devices and several Biocidal products in the Nordic regions.
We are constantly searching for opportunities to in-license more products to our pipeline.
Company summary
The company’s primary goal is to provide patients and the market with more efficient and safer products, especially in those areas where these needs have not been met or are unsatisfied.
Markets and services
DRUGSSON distributes products such as Medical devices, Biocides and Pharmaceuticals to the Nordic regions as well as the non-regulated markets. DRUGSSON’s distribution channels comprise of Pharmacies (both online and physical), hospitals, companies/industries, supermarkets and laboratories.
